12 completed, 2 recruiting, 2 withdrawn, 1 enrolling by invitation. 7 Phase 4, 4 Phase 2, 4 Phase 3, 3 Not applicable, 2 Phase 1.
Follow Human Chorionic Gonadotropin (hCG): new trials by email Literature Review of Human Chorionic Gonadotropin (hCG) trials Research Report on Human Chorionic Gonadotropin (hCG)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Purpose to Evaluate the Effectiveness of the Superovulation Stimulation Protocol Using Human Chorionic Gonadotropin (hCG) by Demonstrating Its Equivalence to Standard Controlled Ovarian Stimulation Protocols in Terms of Oocytes Retrieved, Blastulation While Maintaining an Economic Advantage Human Chorionic Gonadotropin (hCG), GnRH antagonist, Dual trigger (human chorionic gonadotropin plus GnRH-agonist) - Infertility (IVF Patients), Infertility Assisted Reproductive Technology | Not applicable | Enrolling by invitation | LTD "EKODNIPRO", Medical centre Medical Plaza Dnipro | 360 | 2026-08-17 | 2026-08-27 |
| Efficacy of Human Chorionic Gonadotropin in Acute GVHD Treatment Human chorionic gonadotropin (hCG), Prednisone, Dexamethasone - Acute Graft Versus Host Disease | Phase 2 | Recruiting | Hospital Universitario Dr. Jose E. Gonzalez | 20 | 2025-02-01 | 2025-04-03 |
| Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST) Human chorionic gonadotropin (hCG), Follitropin delta, Triptorelin - Low Ovarian Reserve, Poor Ovarian Response | Phase 3 | Recruiting | Fundación para la Investigación del Hospital Clínico de Valencia | 126 | 2024-09-17 | 2026-09-11 |
| HUMAN CHORIONIC GONADOTROPIN (HcG) VS MAGNESIUM SULPHATE (MgSo4) AS A TOCOLYTIC AGENT- A RANDOMIZED CONTROLLED TRIAL human chorionic gonadotropin (hCG), Magnesium sulfate - Preterm Labor | Not applicable | Completed | Shaheed Zulfiqar Ali Bhutto Medical University | 70 | 2023-02-15 | 2024-06-07 |
| Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection | Phase 4 | Completed | Damascus University | 50 | 2020-08-22 | 2023-10-24 |
| Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Infertility | Phase 4 | Completed | Damascus University | 50 | 2020-08-22 | 2023-10-24 |
| Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes. Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection | Phase 4 | Completed | Damascus University | 50 | 2019-12-22 | 2023-10-24 |
| Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients. Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection | Phase 4 | Completed | Damascus University | 50 | 2019-12-22 | 2023-10-24 |
| ITT-5 Mechanisms of Spermatogenesis in Man Testosterone 1% Gel, Acyline, Dutasteride - Gonadotropin Deficiency | Phase 2 | Withdrawn | University of Washington | 2019-06-01 | 2019-12-18 | |
| Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility Human Chorionic Gonadotropin (hCG), Gonadotropins, GNRH-A Triptorelin - Female Infertility, Female Infertility Due to Ovulatory Disorder | Phase 1 / Phase 2 | Completed | Lebanese University | 200 | 2018-02-01 | 2023-05-09 |
| Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD Pregnyl® - Graft vs Host Disease | Phase 1 / Phase 2 | Completed | Masonic Cancer Center, University of Minnesota | 53 | 2016-03-01 | 2023-12-14 |
| Intrauterine Injection of Human Chorionic Gonadotropin Before Embryo Transfer in Women With Previous IVF Failure Human Chorionic Gonadotropin (HCG) - Infertility, Invitro Fertilization | Phase 4 | Unknown | Mansoura University | 380 | 2014-10-01 | 2014-12-31 |
| An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029) MK-8962, recFSH, Ganirelix - Infertility | Phase 3 | Withdrawn | Organon and Co | 2014-03-01 | 2022-02-03 | |
| Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel COL-1620, Gonadotropin-releasing hormone (GnRH) analogue, Follicle-stimulating hormone (FSH) - Luteal Hormone Supplementation in In-vitro Fertilization, Embryo Transfer | Phase 3 | Completed | Merck KGaA, Darmstadt, Germany | 178 | 2013-07-01 | 2015-12-21 |
| Effect of hCG on Receptivity of the Human Endometrium human chorionic gonadotropin (hCG), Placebo Comparator (for hCG) - Infertility, Subfertility | Phase 4 | Completed | Michigan State University | 15 | 2013-01-01 | 2017-02-24 |
| Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF) Menotrophin, Follitrophin alpha, Cetrorelix - Infertility | Phase 4 | Completed | Ferring Pharmaceuticals | 124 | 2010-10-01 | 2014-03-14 |
| A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism Recombinant human luteinizing hormone (r-hLH), Recombinant human follicle-stimulating hormone (r-hFSH), Human chorionic gonadotropin (hCG) - Hypogonadism | Phase 3 | Completed | Merck KGaA, Darmstadt, Germany | 31 | 2004-02-01 | 2013-12-27 |
| Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury. Human chorionic gonadotropin (hCG), Luteinizing hormone releasing hormone (LHRH) - Hypogonadism, Spinal Cord Injury | Not applicable | Completed | US Department of Veterans Affairs | 100 | 2001-07-01 | 2008-03-11 |
Infertility (11) · Hypogonadism (3) · Polycystic Ovary Syndrome (3) · Infertility, Female (2) · Endometriosis (1) · Endometritis (1) · Graft vs Host Disease (1) · Leiomyoma (1) · Obstetric Labor, Premature (1) · Pituitary Diseases (1) · Pregnancy, Ectopic (1) · Primary Ovarian Insufficiency (1) · Salpingitis (1) · Spinal Cord Injuries (1) · Uterine Anomalies (1)
Damascus University (4) · Merck KGaA, Darmstadt, Germany (2) · Ferring Pharmaceuticals (1) · Fundación para la Investigación del Hospital Clínico de Valencia (1) · Hospital Universitario Dr. Jose E. Gonzalez (1) · LTD "EKODNIPRO", Medical centre Medical Plaza Dnipro (1) · Lebanese University (1) · Mansoura University (1) · Masonic Cancer Center, University of Minnesota (1) · Michigan State University (1) · Organon and Co (1) · Shaheed Zulfiqar Ali Bhutto Medical University (1) · US Department of Veterans Affairs (1) · University of Washington (1)
Syria (4) · United States (4) · China (1) · Egypt (1) · Germany (1) · Japan (1) · Lebanon (1) · Mexico (1) · Pakistan (1) · Spain (1) · Uganda (1) · Ukraine (1)
Abdul Hakim Nattouf, MD, PhD (4) · Marwan Alhalabi, MD, PhD (4) · Sally Kadoura, B Pharm, MD (4) · Ahmed Gibreel, MD (1) · Asgerally T. Fazleabas, PhD (1) · Cesar Lizan Tudela (1) · Mara Roth, MD (1) · Nehman Makdissy, Professor (1) · Oleksandr O. Plyh, MD (1) · Samar El Hamoui, Dr (1) · Shernan Holtan, MD (1) · William Bauman, MD (1) · William J Bremner, MD, PhD (1)
PMID 27122490, PMID 32236525, PMID 37279855, PMID 7557841, PMID 8487676